from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0252/nirB

LFCtreatmentdescriptionclass of inhibitor

-0.742

Amikacinug/mL Amikacintranslation

-0.783

Cap5-10ug/mL Capreomycintranslation

-1.013

Rox10-50 ug/mL Roxithromycintranslation

-0.782

SM2-5 ug/mL Streptomycintranslation

-0.500

Tet5-10 ug/mL Tetracyclinetranslation

0.510

Rif0.2-5ug/mL Rifampicintranscription

-0.130

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.681

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.881

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.050

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.950

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.856

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.142

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.087

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.498

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.516

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.689

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.526

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.289

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.832

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.459

KCN5-20 ug/mL Potassium cyaniderespiration

-0.152

NaN30.2-2 mM Sodium aziderespiration

0.545

Nigericin50 uM Nigericinrespiration

0.334

TRC10-150 ug/mL Triclosanrespiration

-0.231

TRZ10-25 ug/mL Thioridazinerespiration

0.823

Valinomycin0.5-10 uM Valinomycinrespiration

-1.409

ZnSO42 mM ZnSO4respiration

1.007

menadione6-10 ug/mL Menadionerespiration

-0.225

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.669

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.347

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.282

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.487

NRP_1Non-replicating persistence stage 1dosRassociated

-0.234

Amp0.2mg/mL AmpicillincellWall

-1.018

Cephalexin20-100 ug/mL CephalexincellWall

-0.437

Cerulenin0.32-5 ug/mL CerulenincellWall

0.480

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.292

EMB10-20 ug/mL EthambutolcellWall

-1.136

Eta12-40 ug/mL EthionamidecellWall

-1.519

INH0.2-0.4 ug/mL IsoniazidcellWall

0.061

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.068

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.599

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.233

BZA0.12 mg/mL BenzamidearomaticAmides

0.077

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.325

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.353

H2O24 mM hydrogen peroxideDNAdamaging

-0.381

Levo10 ug/mL LevofloxacinDNAdamaging

0.384

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.145

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.353

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.506

UVUV-irradiationDNAdamaging

0.735

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.132

Antimycin12.5-50 ug/mL Antimycin A?

0.901

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.153

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.277

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.310

PA8240.2-2 ug/mL PA-824?

-0.987

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.941

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.343

Verapamil50 uM Verapamil?

0.538

mercaptoethanol2 mM 2-Mercaptoethanol?

0.074

methoxatin10-20 ug/mL Methoxatin?